3.82
                                            Precedente Chiudi:
              $4.20
            Aprire:
              $4.15
            Volume 24 ore:
                131.92K
            Relative Volume:
              0.05
            Capitalizzazione di mercato:
                $26.71M
            Reddito:
              -
            Utile/perdita netta:
              $-33.65M
            Rapporto P/E:
              -0.8584
            EPS:
                -4.45
            Flusso di cassa netto:
                $-20.83M
            1 W Prestazione:
              -15.67%
            1M Prestazione:
              +81.90%
            6M Prestazione:
                +124.71%
            1 anno Prestazione:
              +45.80%
            Minerva Neurosciences Inc Stock (NERV) Company Profile
Nome
                  
                      Minerva Neurosciences Inc
                    
                Settore
                  Industria
                  Telefono
                  
                      617-600-7373
                    
                Indirizzo
                  
                      1601 TRAPELO ROAD, WALTHAM, MA
                    
                Confronta NERV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                NERV
                            
                             
                        Minerva Neurosciences Inc 
                           | 
                    3.82 | 29.37M | 0 | -33.65M | -20.83M | -4.45 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Minerva Neurosciences Inc Stock (NERV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione | 
|---|---|---|---|
| 2020-06-08 | Reiterato | H.C. Wainwright | Buy | 
| 2020-05-14 | Iniziato | BTIG Research | Buy | 
| 2019-10-02 | Reiterato | Chardan Capital Markets | Buy | 
| 2019-09-25 | Iniziato | Chardan Capital Markets | Buy | 
| 2019-09-18 | Iniziato | William Blair | Outperform | 
| 2019-05-31 | Iniziato | H.C. Wainwright | Buy | 
| 2017-09-01 | Iniziato | Citigroup | Buy | 
| 2017-03-06 | Ripresa | Jefferies | Buy | 
| 2016-05-12 | Ripresa | Jefferies | Buy | 
                    Mostra tutto
                    
                  
                Minerva Neurosciences Inc Borsa (NERV) Ultime notizie
Regression analysis insights on Minerva Neurosciences Inc. performanceGold Moves & Technical Entry and Exit Tips - newser.com
Real time scanner hits for Minerva Neurosciences Inc. explainedQuarterly Growth Report & Weekly High Return Opportunities - newser.com
Why Minerva Neurosciences Inc. (4MNA) stock benefits from AI revolutionJuly 2025 Fed Impact & Fast Entry High Yield Stock Tips - newser.com
Published on: 2025-11-04 02:32:25 - newser.com
How risky is Minerva Neurosciences Inc. stock nowJuly 2025 Analyst Calls & Community Verified Swing Trade Signals - newser.com
Is Minerva Neurosciences Inc. stock ready for a breakoutIPO Watch & Risk Controlled Swing Alerts - newser.com
Will Minerva Neurosciences Inc. stock keep outperforming rivalsMarket Volume Summary & Expert Curated Trade Setups - newser.com
Visualizing Minerva Neurosciences Inc. stock with heatmapsJuly 2025 Review & Weekly High Potential Alerts - newser.com
Is Minerva Neurosciences Inc. (4MNA) stock positioned for secular growthJuly 2025 Spike Watch & Low Risk High Win Rate Stock Picks - newser.com
How buybacks impact Minerva Neurosciences Inc. stock valueMarket Weekly Review & AI Powered Buy/Sell Recommendations - newser.com
Technical analysis overview for Minerva Neurosciences Inc. stockJuly 2025 EndofMonth & Real-Time Stock Movement Alerts - newser.com
Using Ichimoku Cloud for Minerva Neurosciences Inc. technicalsMarket Volume Summary & Entry and Exit Point Strategies - newser.com
Is Minerva Neurosciences Inc. stock overvalued by current metrics2025 Market Outlook & Community Verified Trade Alerts - newser.com
Why Minerva Neurosciences Inc. stock is seen as undervaluedJuly 2025 Closing Moves & Fast Exit/Entry Strategy Plans - newser.com
Will Minerva Neurosciences Inc. stock continue upward momentumMarket Performance Report & Free Real-Time Volume Trigger Notifications - newser.com
Published on: 2025-11-03 04:45:50 - newser.com
Will Minerva Neurosciences Inc. stock sustain high P E ratiosJuly 2025 Summary & Daily Technical Forecast Reports - newser.com
How interest rate cuts could boost Minerva Neurosciences Inc. stockWeekly Loss Report & Weekly Sector Rotation Insights - newser.com
Will earnings trigger a reversal in Minerva Neurosciences Inc.2025 Big Picture & Fast Gain Swing Alerts - newser.com
Multi asset correlation models including Minerva Neurosciences Inc.Earnings Trend Report & Capital Efficient Trade Techniques - newser.com
What to do if you’re stuck in Minerva Neurosciences Inc.IPO Watch & Accurate Technical Buy Alerts - newser.com
Is Minerva Neurosciences Inc. stock vulnerable to regulatory risksEarnings Performance Report & Weekly Setup with High ROI Potential - newser.com
Will Minerva Neurosciences Inc. (4MNA) stock outperform global peersWeekly Trading Summary & Risk Managed Investment Strategies - newser.com
Heatmap analysis for Minerva Neurosciences Inc. and competitorsForecast Cut & High Win Rate Trade Alerts - newser.com
Does Minerva Neurosciences Inc. stock trade at a discount to peers2025 Short Interest & Capital Efficiency Focused Ideas - newser.com
Will Minerva Neurosciences Inc. stock deliver shareholder valueTrade Exit Summary & Weekly High Return Forecasts - newser.com
Analyzing net buyer seller activity in Minerva Neurosciences Inc.2025 Trade Ideas & AI Based Buy/Sell Signal Reports - newser.com
Volume spikes in Minerva Neurosciences Inc. stock – what they meanJuly 2025 Summary & Real-Time Market Sentiment Reports - newser.com
Is Minerva Neurosciences Inc. stock attractive for income investorsJuly 2025 Market Mood & Low Drawdown Momentum Ideas - newser.com
Automated trading signals detected on Minerva Neurosciences Inc.Treasury Yields & Technical Analysis for Trade Confirmation - newser.com
Combining machine learning predictions for Minerva Neurosciences Inc.Swing Trade & Daily Price Action Insights - newser.com
Will Minerva Neurosciences Inc. (4MNA) stock extend growth story2025 Dividend Review & Fast Entry Momentum Alerts - newser.com
Minerva Neurosciences Inc Azioni (NERV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
        Apri su Yahoo
        |
        Apri su Google
            |
            Aperto in Finviz
        |
        Apri in MarketWatch
            |
            Aperto a EDGAR    
        |
        Aperto su Reuters
    
    
                Capitalizzazione:
                 
                  | 
                Volume (24 ore):